The pitch is straightforward. For a professional who wants to avoid the jitters of a third coffee, or a student cramming for finals, a piece of gum is a simpler, faster, and more portable solution than a drink. Neuro Gum & Mints has spent the last nine years building a business on that premise, turning a functional supplement into a consumer packaged good you can find at the CVS checkout. The bet is that convenience, backed by specific doses of ingredients like caffeine and L-theanine, can carve out a durable slot in the crowded wellness aisle. The early returns, if the company's reported figures are accurate, suggest the wedge is working.
Founded in 2015 by lifelong friends and athletes Kent Yoshimura and Ryan Chen, Neuro started as a direct-to-consumer brand. The core innovation was format: delivering nootropic and adaptogenic ingredients through sugar-free, aspartame-free chewing gum and mints. The product lines are segmented by function, with each targeting a specific mental state.
| Metric | Value |
|---|---|
| Energy & Focus Gum | 60 mg L-theanine |
| Calm & Clarity Gum | 130 mg GABA |
| Memory & Focus Gum | 200 mg ginseng |
The wedge of convenience and clinical dosing
Neuro's primary competition isn't other gum companies. It's the energy drink in the cooler and the coffee pot in the break room. The company positions its products as a cleaner, steadier alternative, promising focus without a crash [neurogum.com]. The real differentiation, however, lies in the combination of delivery method and transparent, science-adjacent dosing. By publishing the milligram amounts of key ingredients like GABA and ginseng, Neuro appeals to a biohacking-curious audience that reads labels. This moves the product from an impulse candy purchase into the realm of intentional cognitive support, a category with higher margins and more loyal customers. The gum and mint format itself is the distribution advantage, allowing for placement in high-traffic retail locations where beverages or pills wouldn't fit.
Traction beyond the DTC playbook
For a company that appears to have operated largely without traditional venture capital until recently, Neuro's retail footprint is notable. The brand is now carried by major national chains including CVS, Walmart, Whole Foods, Target, and Albertsons [neurogum.com]. This omnichannel reach is the engine behind the company's reported financial momentum. Multiple sources, including a 2026 Inc. profile, state the company brings in over $10 million in revenue each month, with annual revenue projected at approximately $120 million [Inc.com, 2026]. Those figures would support a valuation cited at over $100 million [Inc.com, 2026]. A seed round of roughly $8.3 million was reported in 2023, with BAM Ventures listed as a lead investor in some filings, suggesting institutional validation of the retail scale [tracxn.com, 2026].
The founder-led operational thesis
The company's narrative is deeply tied to its founders' backgrounds. CEO Kent Yoshimura is a multimedia artist and former competitive judoka who trained at the Kodokan in Japan [medium.com, 2026]. COO Ryan Chen is a former Paralympic training athlete with a background in business [voyagela.com, 2026]. Their story is one of applying personal experience with performance and focus to a consumer product. This founder-market fit resonates in branding, but the operational test is different. Scaling a CPG brand into national retail requires expertise in logistics, broker relationships, and trade spend management,skills often honed at large incumbent companies. The team's ability to navigate this, evidenced by their shelf placement, suggests they have built or hired that competency.
The crowded field and the durability question
The functional gum space is not uncontested. Neuro's realistic competitive set includes several other players aiming for the same consumer need state.
| Competitor | Primary Claim / Differentiation |
|---|---|
| Run Gum | Energy gum founded by an Olympic athlete, focused on caffeine for athletic performance. |
| Viter Energy | Caffeine-infused mints, often marketed as a coffee alternative. |
| WUG Functional Gums | Variety of functional ingredients (e.g., melatonin, vitamin B12) in gum format. |
| Military Energy Gum | Very high caffeine content (100mg per piece) targeted at specific tactical use. |
Neuro's most credible risk isn't a direct competitor, but the classic CPG challenge of sustaining brand relevance and shelf space in a category prone to fads. The "functional" label can attract scrutiny from regulators, and retail buyers are quick to delist products if velocity slows. The company's answer appears to be a focus on specific, clinically-relevant formulations and a brand built on a founder story that is harder to commoditize than a simple caffeine gum. Their appearance on Shark Tank in 2020, while a deal did not ultimately close, provided a national awareness boost that likely aided early retail conversations [instagram.com].
What enterprise buyers are saying
The ideal customer profile here isn't a procurement officer at a Fortune 500 company. It's the inventory manager at a regional grocery chain or the category merchant at a national drugstore. For them, Neuro represents a high-margin SKU in the growing wellness segment, with a brand that has demonstrated pull-through via its DTC channel. The product's format allows for placement in multiple parts of the store,at checkout for impulse, in the vitamin aisle for intentional purchase,which increases its sales potential per square foot. The real test for Neuro's account managers will be proving repeat purchase rates and defending their facings against the next wave of functional snacks. For now, the reported $10 million monthly run rate suggests they are winning that argument at the buyer level.
Looking ahead, the next twelve months will test the brand's durability. The company must demonstrate that its products drive repeat purchases, not just novelty trials. Expanding the line with new formulations or adjacent products could help, but the core focus will be on maintaining velocity in its existing retail partners. With a reported seed round now behind it, the company has capital to invest in brand marketing and trade promotions to secure its position. In a market crowded with promises of better focus and energy, Neuro has managed to get its promise onto physical shelves where the battle for consumer attention is fought daily. That, in the CPG world, is the first and most critical milestone.
Sources
- [neurogum.com] About Neuro | https://neurogum.com/pages/about-neuro
- [innerbody.com] Neuro Gum Review | https://www.innerbody.com/neuro-gum-review
- [Inc.com, 2026] Neuro Gum profile and revenue figures | https://www.inc.com
- [tracxn.com, 2026] Neuro funding round details | https://tracxn.com
- [medium.com, 2026] Kent Yoshimura background | https://medium.com
- [voyagela.com, 2026] Ryan Chen background | https://voyagela.com
- [instagram.com] Shark Tank appearance reference | https://www.instagram.com/reel/DVt1Se0kT8U/